Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBT (2022 - 2025)

ASP Isotopes has reported EBT over the past 4 years, most recently at -$63.1 million for Q4 2025.

  • For Q4 2025, EBT fell 596.36% year-over-year to -$63.1 million; the TTM value through Dec 2025 reached -$159.6 million, down 393.81%, while the annual FY2025 figure was -$159.6 million, 393.81% down from the prior year.
  • EBT for Q4 2025 was -$63.1 million at ASP Isotopes, down from -$12.8 million in the prior quarter.
  • Over five years, EBT peaked at -$827959.0 in Q2 2022 and troughed at -$75.1 million in Q2 2025.
  • A 4-year average of -$13.3 million and a median of -$5.6 million in 2023 define the central range for EBT.
  • On a YoY basis, EBT climbed as much as 21.67% in 2025 and fell as far as 746.47% in 2025.
  • Year by year, EBT stood at -$1.5 million in 2022, then crashed by 186.53% to -$4.2 million in 2023, then crashed by 117.13% to -$9.1 million in 2024, then tumbled by 596.36% to -$63.1 million in 2025.
  • Business Quant data shows EBT for ASPI at -$63.1 million in Q4 2025, -$12.8 million in Q3 2025, and -$75.1 million in Q2 2025.